Sami-Sabinsa Group Limited
Biotechnology Research • 
Peenya 2Stage Road, Sami-Sabinsa Group Limited, India • 501-1000 Employees
Company overview
| Headquarters | Peenya 2Stage Road, Sami-Sabinsa Group Limited, India |
| Phone number | +918068527777 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Nutraceuticals, Probiotics, Dietary Supplements, Cosmeceuticals, Contract Farming, Fine Chemicals, Speciality Chemicals, Standardized Herbal Extracts |
| Founded | 1988 |
| Employees | 501-1000 |
| Socials |
Key Contacts at Sami-Sabinsa Group Limited
Shaheen Majeed
Global Ceo & Managing Director
Srinivasa R Pharma Industry
Director - Quality & Regulatory Affairs
Dasari D Nageswara
Bronze Director
Vg Nair
Chief Executive Officer
Shubham Pandey
Director At Sami Direct
Sami Sawalha
Owner
Sami-Sabinsa Group Limited Email Formats
Sami-Sabinsa Group Limited uses 5 email formats. The most common is {first name} (e.g., john@samilabs.com), used 69.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@samilabs.com | 83.6% |
{first initial}{last name} | jdoe@samilabs.com | 12.7% |
{first name}.{last name} | john.doe@samilabs.com | 3.6% |
About Sami-Sabinsa Group Limited
Sami-Sabinsa Group Limited (formerly Sami Labs Ltd), a pioneer and global leader in health science, is a leading producer of nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals, probiotics and enzymes. Founded in 1988 by Dr. Muhammed Majeed, an internationally acclaimed scientist turned entrepreneur in the field of Evidence Based Medicine, the Group has independent research divisions including Natural Drugs, Phytochemistry, Synthetic Chemistry, Tissue Culture, Biotechnology, Analytical R&D, Biological Research, Microbiology, and Formulations R&D all of which coordinate in a synergistic work model to create products meeting international standards. A team of over 120 research scientists work tirelessly to discover and develop standardized natural extracts that render alternative therapy to emerging nutritional and health requirements across the globe. Demonstrating its commitment to sustainable development, Sami-Sabinsa Group, under the visionary leadership of Dr. Majeed, pioneered the contract farming model deploying close to 20,000 acres of land in India. The Group has a sizeable patent portfolio comprising over 500+ granted patents and several pending patent applications worldwide. Sami-Sabinsa Group manufactures its products as per global standards at its seven state-of-the-art manufacturing facilities located in Bengaluru, Hyderabad and Utah (USA). Our Bengaluru and Hyderabad facilities are FSSC 22000, FSSAI and USP GMP certified and our US facility is NSF GMP certified. The Sami-Sabinsa group is a global organization with a presence in 13 countries that include the USA (New Jersey & Utah), Australia, Canada, China, Germany, India, Japan, Poland, South Africa, South Korea, Brazil, UAE, and Vietnam.
Sami-Sabinsa Group Limited revenue & valuation
| Annual revenue | $158,700,000 |
| Revenue per employee | $220,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $507,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 501-1000
Seniority
Employees
Employees by Department
Sami-Sabinsa Group Limited has 289 employees across 14 departments.
Departments
Number of employees
Funding Data
Sami-Sabinsa Group Limited has never raised funding before.
Sami-Sabinsa Group Limited Tech Stack
Discover the technologies and tools that power Sami-Sabinsa Group Limited's digital infrastructure, from frameworks to analytics platforms.
CMS
Security
JavaScript libraries
Maps
UI frameworks
Widgets
JavaScript libraries
Miscellaneous
JavaScript libraries
CDN
JavaScript libraries
Singapore
South Africa
Chile
United KingdomFrequently asked questions
4.8
40,000 users
